|
US4189604A
(en)
|
1975-07-22 |
1980-02-19 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Bestatin
|
|
CA1108180A
(en)
|
1976-07-21 |
1981-09-01 |
Hamao Umezawa |
Analogs of bestatin
|
|
US4165382A
(en)
*
|
1977-10-17 |
1979-08-21 |
Jose Pozuelo |
Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
|
|
US4117161A
(en)
|
1977-05-16 |
1978-09-26 |
Jose Pozuelo |
Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
|
|
US5206018A
(en)
|
1978-11-03 |
1993-04-27 |
Ayerst, Mckenna & Harrison, Inc. |
Use of rapamycin in treatment of tumors
|
|
US5683981A
(en)
|
1987-05-22 |
1997-11-04 |
Competitive Technologies, Inc. |
Cyclic bridged analogs of α-MSH and methods thereof
|
|
US5674839A
(en)
|
1987-05-22 |
1997-10-07 |
Competitive Technologies, Inc. |
Cyclic analogs of alpha-MSH fragments
|
|
US5073541A
(en)
|
1987-11-18 |
1991-12-17 |
Administrators Of The Tulane Educational Fund |
Treatment of small cell lung cancer with somatostatin analogs
|
|
US5225435A
(en)
|
1990-05-18 |
1993-07-06 |
Yale University |
Soluble melanin
|
|
WO1994022460A1
(en)
|
1993-04-05 |
1994-10-13 |
University Patents, Inc. |
Diagnosis and treatment of erectile dysfunction
|
|
IT1291633B1
(it)
|
1997-04-22 |
1999-01-11 |
Pharmaconsult S A S |
Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride
|
|
US20030059471A1
(en)
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
JP4394279B2
(ja)
|
1998-03-09 |
2010-01-06 |
ジーランド ファーマ アクティーゼルスカブ |
酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
|
|
WO2000010507A2
(en)
|
1998-08-21 |
2000-03-02 |
The Children's Medical Center Corporation |
Use of melanin for inhibition of angiogenesis and macular degeneration
|
|
AU2001251595A1
(en)
|
2000-04-13 |
2001-10-30 |
William T Evans |
Gaba substrate and the use thereof for treating cognitive and emotional disorders
|
|
US20030114362A1
(en)
|
2001-06-08 |
2003-06-19 |
Novaspin Biotech Gmbh |
Penta-or tetrapeptide binding to somatostatin receptors and the use of the same
|
|
MXPA05010945A
(es)
|
2003-04-09 |
2005-11-25 |
Japan Tobacco Inc |
Compuesto pentaciclico heteroaromatico y uso medicinal del mismo.
|
|
CA2582346A1
(en)
|
2004-10-01 |
2006-04-13 |
The Research Foundation Of State University Of New York |
Morphine and morphine precursors
|
|
EP2455072A1
(en)
|
2005-03-11 |
2012-05-23 |
Endo Pharmaceuticals Solutions Inc. |
Controlled release formulations of octreotide
|
|
ATE431140T1
(de)
|
2005-03-11 |
2009-05-15 |
Gpc Biotech Ag |
Antiproliferative kombinations-therapie mit satraplatin oder jm118 und docetaxel
|
|
WO2009054001A1
(en)
|
2007-10-22 |
2009-04-30 |
Biocon Limited |
A pharmaceutical composition and a process thereof
|
|
CN101965192A
(zh)
|
2008-03-07 |
2011-02-02 |
法马马有限公司 |
改善的抗肿瘤治疗
|
|
US20110098241A1
(en)
|
2008-04-14 |
2011-04-28 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
|
US8003689B2
(en)
|
2008-06-20 |
2011-08-23 |
Gtx, Inc. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
|
CA2734828C
(en)
|
2008-08-20 |
2018-07-24 |
J. Silvio Gutkind |
Chemoprevention of head and neck squamous cell carcinomas
|
|
US8110578B2
(en)
|
2008-10-27 |
2012-02-07 |
Signal Pharmaceuticals, Llc |
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
|
|
AU2010233073B2
(en)
|
2009-04-10 |
2014-07-31 |
Haiyan Qi |
Novel anti-aging agents and methods to identify them
|
|
WO2011112576A1
(en)
|
2010-03-10 |
2011-09-15 |
Ambrilia Biopharma Inc. |
Microspheres for sustained release of octreotide acetate
|
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
|
WO2012123819A1
(en)
|
2011-03-15 |
2012-09-20 |
Optinose As Et Al |
Nasal delivery
|
|
PL220308B1
(pl)
|
2011-06-03 |
2015-10-30 |
Kobel Buys Krystyna |
Zastosowanie klenbuterolu do leczenia objawów autyzmu dziecięcego oraz klenbuterol do zastosowania w leczeniu objawów autyzmu dziecięcego
|
|
US20130183263A1
(en)
|
2012-01-17 |
2013-07-18 |
Steven Hoffman |
Pharmaceutical compositions and methods
|
|
US8481498B1
(en)
|
2012-01-17 |
2013-07-09 |
Steven Hoffman |
Pharmaceutical compositions and methods
|
|
US9763903B2
(en)
*
|
2013-10-22 |
2017-09-19 |
Steven Hoffman |
Compositions and methods for treating intestinal hyperpermeability
|
|
US9326962B2
(en)
*
|
2013-10-22 |
2016-05-03 |
Steven Hoffman |
Compositions and methods for treating intestinal hyperpermeability
|
|
US10751313B2
(en)
*
|
2013-10-22 |
2020-08-25 |
Yamo Pharmaceuticals Llc |
Compositions and methods for treating autism
|
|
US10813901B2
(en)
*
|
2013-10-22 |
2020-10-27 |
Yamo Pharmaceuticals Llc |
Compositions and methods for treating autism
|
|
US20150111878A1
(en)
|
2013-10-22 |
2015-04-23 |
Steven Hoffman |
Compositions and methods for treating intestinal hyperpermeability
|
|
KR20180015126A
(ko)
*
|
2015-04-14 |
2018-02-12 |
스티븐 호프만 |
자폐증을 치료하기 위한 조성물 및 방법
|